z-logo
Premium
Expanding the phenotypic spectrum consequent upon de novo WDR37 missense variants
Author(s) -
Hay Eleanor,
Henderson Robert H.,
Mansour Sahar,
Deshpande Charu,
Jones Rachel,
Nutan Savita,
Mankad Kshitij,
Young Rodrigo M.,
Moosajee Mariya,
Research Consortium Genomics England,
Arno Gavin
Publication year - 2020
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.13795
Subject(s) - missense mutation , coloboma , phenotype , genetics , intellectual disability , epilepsy , biology , medicine , bioinformatics , gene , neuroscience
Structural eye disorders are increasingly recognised as having a genetic basis, although current genetic testing is limited in its success. De novo missense variants in WDR37 are a recently described cause of a multisystemic syndromic disorder featuring ocular coloboma. This study characterises the phenotypic spectrum of this disorder and reports 2 de novo heterozygous variants (p.Thr115Ile, p.Ser119Tyr) in three unrelated Caucasian individuals. All had a clinical phenotype consisting of bilateral iris and retinal coloboma, developmental delay and additional, variable multisystem features. The variants fall within a highly conserved region upstream of the WD‐repeat domains, within an apparent mutation cluster. Consistent with the literature, intellectual disability, structural eye disorders, epilepsy, congenital heart disease, genitorenal anomalies and dysmorphic facial features were observed. In addition, a broader developmental profile is reported with a more specific musculoskeletal phenotype described in association with the novel variant (p.Thr115Ile). We further expand the phenotypic spectrum of WDR37 ‐related disorders to include those with milder developmental delay and strengthen the association of ocular coloboma and musculoskeletal features. We promote the inclusion of WDR37 on gene panels for intellectual disability, epilepsy and structural eye disorders.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here